Skip to main content


Fig. 4 | Cell & Bioscience

Fig. 4

From: miR-26a inhibits atherosclerosis progression by targeting TRPC3

Fig. 4

miR-26a overexpression attenuated the development of atherosclerosis in ox-LDL-treated HAECs. HAECs were transfected with miR-26a or miR-NC, followed by treatment with 50 nM ox-LDL for 24 h. a RT-qPCR analysis of miR-26a expression in treated HAECs. The concentrations of TNF-α (b), IL-1β (c), IL-6 (d), and MCP-1 (e) in the supernatant of treated HAECs were measured by ELISA assay. f Cell viability of treated HAECs was estimated by MTT assay. g Apoptosis of treated HAECs was assessed by TUNEL assay. *P < 0.05

Back to article page